Akeso Inc
HKEX:9926

Watchlist Manager
Akeso Inc Logo
Akeso Inc
HKEX:9926
Watchlist
Price: 83.8 HKD -3.62% Market Closed
Market Cap: 75.2B HKD

Wall Street
Price Targets

Price Targets Summary
Akeso Inc

Wall Street analysts forecast Akeso Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Akeso Inc is 106.49 HKD with a low forecast of 65.65 HKD and a high forecast of 157.5 HKD.

Lowest
Price Target
65.65 HKD
22% Downside
Average
Price Target
106.49 HKD
27% Upside
Highest
Price Target
157.5 HKD
88% Upside
Akeso Inc Competitors:
Price Targets
300896
Imeik Technology Development Co Ltd
33% Upside
CVAC
CureVac NV
41% Upside
COYA
Coya Therapeutics Inc
208% Upside
603087
Gan & Lee Pharmaceuticals
14% Upside
BRNS
Barinthus Biotherapeutics PLC
325% Upside
1530
3SBio Inc
36% Downside
ELIC
Elicera Therapeutics AB
31% Downside
206650
EuBiologics Co Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Akeso Inc

For the last 5 years the compound annual growth rate for Akeso Inc's revenue is 97%. The projected CAGR for the next 3 years is 56%.

97%
Past Growth
56%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Akeso Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Akeso Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Akeso Inc's stock price target?
Price Target
106.49 HKD

According to Wall Street analysts, the average 1-year price target for Akeso Inc is 106.49 HKD with a low forecast of 65.65 HKD and a high forecast of 157.5 HKD.

What is Akeso Inc's Revenue forecast?
Projected CAGR
56%

For the last 5 years the compound annual growth rate for Akeso Inc's revenue is 97%. The projected CAGR for the next 3 years is 56%.

Back to Top